ioGenetics Overview

  • Year Founded
  • 2000

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 4

ioGenetics General Information

Description

Developer of antimicrobial proteins designed to treat difficult infections. The company's proteins are developed through an integrated pipeline that includes the platform technologies to efficiently design and produce a diverse array of recombinant proteins, enabling patients to get effective relief from infections.

Contact Information

Website
www.iogenetics.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Corporate Office
  • 3591 Anderson Street
  • Suite 218
  • Madison, WI 53704
  • United States
+1 (608)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Healthcare Technology Systems
Vertical(s)
Life Sciences
Corporate Office
  • 3591 Anderson Street
  • Suite 218
  • Madison, WI 53704
  • United States
+1 (608)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ioGenetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Mar-2022 Completed Generating Revenue
5. Grant 31-Dec-2017 Completed Generating Revenue
4. Grant 31-Dec-2014 Completed Generating Revenue
3. Later Stage VC 21-Dec-2013 Completed Generating Revenue
2. Grant 01-Jan-2009 $7.69M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2001 Completed Startup
To view ioGenetics’s complete valuation and funding history, request access »

ioGenetics Patents

  • 104

    Total Documents Applications and Grants

  • Total Patents Families

  • 47

    Granted

  • 22

    Pending

  • Expiring in next 12 mo

ioGenetics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4326319-A1 Personalized allogeneic immunotherapy Pending 22-Apr-2021
US-20240197878-A1 Personalized allogeneic immunotherapy Pending 22-Apr-2021
EP-4255474-A1 Personalized immunotherapies Pending 07-Dec-2020
EP-4256311-A1 Administration of anti-tumor vaccines Pending 07-Dec-2020
EP-4255465-A1 Bystander protein vaccines Pending 07-Dec-2020 A61K38/1709
To view ioGenetics’s complete patent history, request access »

ioGenetics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Department of Defense Government
National Institute for Allergy and Infectious Disease Government
National Institute of General Medical Sciences Government
Springboard Enterprises Accelerator/Incubator
To view ioGenetics’s complete investors history, request access »

Ready to get started?

Request a free trial

ioGenetics FAQs

  • When was ioGenetics founded?

    ioGenetics was founded in 2000.

  • Where is ioGenetics headquartered?

    ioGenetics is headquartered in Madison, WI.

  • What industry is ioGenetics in?

    ioGenetics’s primary industry is Drug Discovery.

  • Is ioGenetics a private or public company?

    ioGenetics is a Private company.

  • What is ioGenetics’s current revenue?

    The current revenue for ioGenetics is .

  • How much funding has ioGenetics raised over time?

    ioGenetics has raised $1.15M.

  • Who are ioGenetics’s investors?

    United States Department of Defense, National Institute for Allergy and Infectious Disease, National Institute of General Medical Sciences, and Springboard Enterprises have invested in ioGenetics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »